OR WAIT 15 SECS
Here's this week's coronavirus-related news you should know.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), has infected an estimated 19,141,627 individuals worldwide, and approximately 4.9 million Americans. The latest COVID-19 related news includes Eli Lilly beginning its LYCoV555 antibody tests, new guidelines on how to care for patients with cancer during the pandemic, and MJH Life Sciences’ webcast focused on the race for a COVID-19 vaccine.
Here’s a roundup of the latest coronavirus-related news:
Long-term care facilities will be the focus of Eli Lilly’s BLAZE-2 study for testing its LY-CoV555 antibody against SARS-CoV-2.
Eli Lilly recently announced the launch of its BLAZE-2 trial for LY-CoV555 in partnership with the National Institute of Allergy and Infectious Diseases for treating COVID-19 in long-term care facilities.
Experts from the European Society for Medical Oncology released changes to recommendations on how to manage patients with cancer during the COVID-19 pandemic.
Despite the risk of being exposed to COVID-19, a new paper urged global oncologists not to delay any type of anti-cancer treatment that may potentially impact overall survival.
Three scientists discussed the global race for a COVID-19 vaccine.
Recently, MJH Life Sciences hosted a webcast, “The race for a vaccine,” with 3 world-renowned scientists leading a lively discussion on the history of vaccines, past and future efficacies within the vaccine world and just what a COVID-19 vaccine might look like in the near future. The panel included Dr Walter A Orenstein, MD, professor and associate director of the Emory Vaccine Center at Emory University School of Medicine; Dr Angela Rasmussen, PhD, associate research scientist at the Center for Infection and Immunity at Columbia University; and Dr Gregory A Poland, MD, editor-in-chief of the journal Vaccine, and director of the Mayo Vaccine Research Group.
New Hampshire joins New York and Minnesota in allowing COVID-19 vaccination access through pharmacy.
New Hampshire has passed into law authorization for pharmacists to administer vaccinations for SARS-CoV-2, the virus that causes COVID-19, once it becomes available.
A panel has given a “weak recommendation” for the use of remdesivir in patients with severe coronavirus disease 2019.
An international panel issued a “weak recommendation” for the use of remdesivir in COVID-19, following review of 2 randomized clinical trials, according to a paper published in The BMJ.
Joshua Miller, MD MPH and medical director of diabetes care for Stony Brook Medicine, discusses continuous glucose monitoring technology, which the FDA has authorized for use in hospitals amid the COVID-19 pandemic.